GENE ONLINE|News &
Opinion
Blog

2025-12-02|

Antibacterial Hydrogel Combining Hydroxyethyl Cellulose and Montmorillonite Clay Developed for Bone Tissue Engineering

by GOAI
Share To

Researchers have developed an antibacterial bionanocomposite hydrogel designed for potential use as a scaffold in bone tissue engineering. The material combines hydroxyethyl cellulose, poly(vinyl alcohol), and montmorillonite clay to create a structure that supports bone regeneration while offering antibacterial properties. This innovation aims to address challenges in bone tissue engineering by providing a biocompatible and functional scaffold.

The study highlights the integration of these components to enhance the mechanical strength, biocompatibility, and antibacterial efficacy of the hydrogel. Hydroxyethyl cellulose contributes to the material’s biocompatibility, while poly(vinyl alcohol) improves its structural integrity. Montmorillonite clay adds antimicrobial properties, which are critical for preventing infections during the healing process. Researchers suggest that this combination could provide a promising platform for future applications in regenerative medicine and bone repair therapies.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 2, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top